BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6480448)

  • 1. Mechanism of melphalan crosslink enhancement by misonidazole pretreatment.
    Taylor YC; Sawyer JM; Hsu B; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1603-7. PubMed ID: 6480448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of chemosensitization by misonidazole in vitro.
    Taylor YC; Bump EA; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):705-8. PubMed ID: 7107402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA; Hall EJ
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
    Smith E; Stratford IJ; Adams GE
    Br J Cancer; 1982 Jul; 46(1):117-26. PubMed ID: 7104191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of sensitization of Chinese hamster ovary cells to melphalan by hypoxic treatment with misonidazole.
    Taylor YC; Evans JW; Brown JM
    Cancer Res; 1983 Jul; 43(7):3175-81. PubMed ID: 6850627
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
    Papadopoulou MV; Ji M; Khan SH; Bloomer WD
    Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR; Evans JW; Brown JM
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misonidazole chemosensitization of EMT6 spheroids to melphalan.
    Horsman MR; Wood PJ; Brown JM
    Radiother Oncol; 1989 May; 15(1):103-14. PubMed ID: 2748937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
    Roizin-Towle L
    J Natl Cancer Inst; 1985 Jan; 74(1):151-7. PubMed ID: 3155814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misonidazole hypoxic cytotoxicity and chemosensitization in two cell lines with different intracellular glutathione levels.
    DeGraff WG; Russo A; Friedman N; Mitchell JB
    Eur J Cancer; 1990 Jan; 26(1):17-20. PubMed ID: 2138473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I; Guttman P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):663-6. PubMed ID: 7107395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ; Hinchliffe M; de Ronde J
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
    Murray D; Meyn RE
    Br J Cancer; 1983 Feb; 47(2):195-203. PubMed ID: 6824567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization by hypoxic pretreatment with misonidazole: an interaction of damage at the DNA level.
    Taylor YC; Evans JW; Brown JM
    Radiat Res; 1987 Mar; 109(3):364-73. PubMed ID: 3550868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitization: do thiols matter?
    Roizin-Towle L; Hall EJ; Costello T; Biaglow JE; Varnes ME
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1599-602. PubMed ID: 6480447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity of melphalan by prolonged exposure to nitroimidazoles: the role of endogenous thiols.
    Roizin-Towle L; Hall EJ; Flynn M; Biaglow JE; Varnes ME
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):757-60. PubMed ID: 7107410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM; Hirst DG
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.